Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1993 May;67(5):1136–1141. doi: 10.1038/bjc.1993.209

Multivariate analysis of prognostic factors in patients with non HIV-related primary cerebral lymphoma. A proposal for a prognostic scoring.

J Y Blay 1, C Lasset 1, C Carrie 1, F Chauvin 1, B Coiffier 1, C Gisselbrecht 1, M Clavel 1, P Rebattu 1, M Brunat-Mentigny 1, T Philip 1, et al.
PMCID: PMC1968460  PMID: 8494713

Abstract

Between 1982 and 1991, 41 patients were treated for non HIV related primary cerebral lymphoma (PCL) in our institute. The purpose of this study was to perform a multivariate analysis of prognostic factors for survival in these patients. The presence of a CSF protein level over 0.6 g l-1 at diagnosis was found to be the most significant unfavourable prognostic factor in univariate analysis and had not previously been reported. Among the five significant prognostic factors at diagnosis, (age over 60 years, performance status--ECOG scale--over 2, memory dysfunction, non hemispheric tumour site, CSF protein level over 0.6 g l-1 at the diagnosis), three independent factors were identified in multivariate analysis: (1) CSF protein level (P = 0.007; RR = 4.7); (2) PS > 2 (P = 0.04, RR = 2.65); (3) age over 60 (P = 0.08; RR = 2.43). Using the regression coefficient of these three parameters, we determined a prognostic index which allowed us to distinguish three risk groups whose theoretical median survival is 4, 20 and 54, months respectively in patients with non HIV related PCL. These results indicate that PCL is an heterogeneous disease in terms of the prognostic in which three subgroups with discriminant survival can be identified.

Full text

PDF
1136

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berry M. P., Simpson W. J. Radiation therapy in the management of primary malignant lymphoma of the brain. Int J Radiat Oncol Biol Phys. 1981 Jan;7(1):55–59. doi: 10.1016/0360-3016(81)90060-2. [DOI] [PubMed] [Google Scholar]
  2. Brada M., Dearnaley D., Horwich A., Bloom H. J. Management of primary cerebral lymphoma with initial chemotherapy: preliminary results and comparison with patients treated with radiotherapy alone. Int J Radiat Oncol Biol Phys. 1990 Apr;18(4):787–792. doi: 10.1016/0360-3016(90)90398-4. [DOI] [PubMed] [Google Scholar]
  3. Byar D. P., Green S. B., Dor P., Williams E. D., Colon J., van Gilse H. A., Mayer M., Sylvester R. J., van Glabbeke M. A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group. Eur J Cancer. 1979 Aug;15(8):1033–1041. doi: 10.1016/0014-2964(79)90291-3. [DOI] [PubMed] [Google Scholar]
  4. Coiffier B., Gisselbrecht C., Herbrecht R., Tilly H., Bosly A., Brousse N. LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma. J Clin Oncol. 1989 Aug;7(8):1018–1026. doi: 10.1200/JCO.1989.7.8.1018. [DOI] [PubMed] [Google Scholar]
  5. DeAngelis L. M., Yahalom J., Heinemann M. H., Cirrincione C., Thaler H. T., Krol G. Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy. Neurology. 1990 Jan;40(1):80–86. doi: 10.1212/wnl.40.1.80. [DOI] [PubMed] [Google Scholar]
  6. DeAngelis L. M., Yahalom J., Thaler H. T., Kher U. Combined modality therapy for primary CNS lymphoma. J Clin Oncol. 1992 Apr;10(4):635–643. doi: 10.1200/JCO.1992.10.4.635. [DOI] [PubMed] [Google Scholar]
  7. Eby N. L., Grufferman S., Flannelly C. M., Schold S. C., Jr, Vogel F. S., Burger P. C. Increasing incidence of primary brain lymphoma in the US. Cancer. 1988 Dec 1;62(11):2461–2465. doi: 10.1002/1097-0142(19881201)62:11<2461::aid-cncr2820621135>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  8. Elson P. J., Witte R. S., Trump D. L. Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma. Cancer Res. 1988 Dec 15;48(24 Pt 1):7310–7313. [PubMed] [Google Scholar]
  9. Freeman C. R., Shustik C., Brisson M. L., Meagher-Villemure K., Dylewski I. Primary malignant lymphoma of the central nervous system. Cancer. 1986 Sep 1;58(5):1106–1111. doi: 10.1002/1097-0142(19860901)58:5<1106::aid-cncr2820580521>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  10. Gill P. S., Levine A. M., Meyer P. R., Boswell W. D., Burkes R. L., Parker J. W., Hofman F. M., Dworsky R. L., Lukes R. J. Primary central nervous system lymphoma in homosexual men. Clinical, immunologic, and pathologic features. Am J Med. 1985 May;78(5):742–748. doi: 10.1016/0002-9343(85)90277-3. [DOI] [PubMed] [Google Scholar]
  11. Gonzalez D. G., Schuster-Uitterhoeve A. L. Primary non-Hodgkin's lymphoma of the central nervous system. Results of radiotherapy in 15 cases. Cancer. 1983 Jun 1;51(11):2048–2052. doi: 10.1002/1097-0142(19830601)51:11<2048::aid-cncr2820511115>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  12. Henry J. M., Heffner R. R., Jr, Dillard S. H., Earle K. M., Davis R. L. Primary malignant lymphomas of the central nervous system. Cancer. 1974 Oct;34(4):1293–1302. doi: 10.1002/1097-0142(197410)34:4<1293::aid-cncr2820340441>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  13. Hochberg F. H., Miller D. C. Primary central nervous system lymphoma. J Neurosurg. 1988 Jun;68(6):835–853. doi: 10.3171/jns.1988.68.6.0835. [DOI] [PubMed] [Google Scholar]
  14. Letendre L., Banks P. M., Reese D. F., Miller R. H., Scanlon P. W., Kiely J. M. Primary lymphoma of the central nervous system. Cancer. 1982 Mar 1;49(5):939–943. doi: 10.1002/1097-0142(19820301)49:5<939::aid-cncr2820490518>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  15. Levitt L. J., Dawson D. M., Rosenthal D. S., Moloney W. C. CNS involvement in the non-Hodgkin's lymphomas. Cancer. 1980 Feb;45(3):545–552. doi: 10.1002/1097-0142(19800201)45:3<545::aid-cncr2820450322>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  16. Loeffler J. S., Ervin T. J., Mauch P., Skarin A., Weinstein H. J., Canellos G., Cassady J. R. Primary lymphomas of the central nervous system: patterns of failure and factors that influence survival. J Clin Oncol. 1985 Apr;3(4):490–494. doi: 10.1200/JCO.1985.3.4.490. [DOI] [PubMed] [Google Scholar]
  17. Longo D. L., DeVita V. T., Jr, Duffey P. L., Wesley M. N., Ihde D. C., Hubbard S. M., Gilliom M., Jaffe E. S., Cossman J., Fisher R. I. Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial. J Clin Oncol. 1991 Jan;9(1):25–38. doi: 10.1200/JCO.1991.9.1.25. [DOI] [PubMed] [Google Scholar]
  18. Mendenhall N. P., Thar T. L., Agee O. F., Harty-Golder B., Ballinger W. E., Jr, Million R. R. Primary lymphoma of the central nervous system. Computerized tomography scan characteristics and treatment results for 12 cases. Cancer. 1983 Dec 1;52(11):1993–2000. doi: 10.1002/1097-0142(19831201)52:11<1993::aid-cncr2820521104>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  19. Michalski J. M., Garcia D. M., Kase E., Grigsby P. W., Simpson J. R. Primary central nervous system lymphoma: analysis of prognostic variables and patterns of treatment failure. Radiology. 1990 Sep;176(3):855–860. doi: 10.1148/radiology.176.3.2389047. [DOI] [PubMed] [Google Scholar]
  20. Murray K., Kun L., Cox J. Primary malignant lymphoma of the central nervous system. Results of treatment of 11 cases and review of the literature. J Neurosurg. 1986 Nov;65(5):600–607. doi: 10.3171/jns.1986.65.5.0600. [DOI] [PubMed] [Google Scholar]
  21. Neuwelt E. A., Frenkel E. P., Gumerlock M. K., Braziel R., Dana B., Hill S. A. Developments in the diagnosis and treatment of primary CNS lymphoma. A prospective series. Cancer. 1986 Oct 15;58(8):1609–1620. doi: 10.1002/1097-0142(19861015)58:8<1609::aid-cncr2820580805>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  22. Neuwelt E. A., Goldman D. L., Dahlborg S. A., Crossen J., Ramsey F., Roman-Goldstein S., Braziel R., Dana B. Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function. J Clin Oncol. 1991 Sep;9(9):1580–1590. doi: 10.1200/JCO.1991.9.9.1580. [DOI] [PubMed] [Google Scholar]
  23. Patte C., Philip T., Rodary C., Zucker J. M., Behrendt H., Gentet J. C., Lamagnère J. P., Otten J., Dufillot D., Pein F. High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children. J Clin Oncol. 1991 Jan;9(1):123–132. doi: 10.1200/JCO.1991.9.1.123. [DOI] [PubMed] [Google Scholar]
  24. Pollack I. F., Lunsford L. D., Flickinger J. C., Dameshek H. L. Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma. Cancer. 1989 Mar 1;63(5):939–947. doi: 10.1002/1097-0142(19890301)63:5<939::aid-cncr2820630526>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  25. Shibamoto Y., Tsutsui K., Dodo Y., Yamabe H., Shima N., Abe M. Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic vincristine-doxorubicin-cyclophosphamide-prednisolone chemotherapy. Cancer. 1990 May 1;65(9):1907–1912. doi: 10.1002/1097-0142(19900501)65:9<1907::aid-cncr2820650906>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  26. Woodman R., Shin K., Pineo G. Primary non-Hodgkin's lymphoma of the brain. A review. Medicine (Baltimore) 1985 Nov;64(6):425–430. doi: 10.1097/00005792-198511000-00006. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES